Compare Z & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | Z | ICLR |
|---|---|---|
| Founded | 2004 | 1990 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Business Services | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.0B | 9.3B |
| IPO Year | 2014 | 2001 |
| Metric | Z | ICLR |
|---|---|---|
| Price | $34.66 | $164.46 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 25 | 13 |
| Target Price | $79.45 | ★ $178.62 |
| AVG Volume (30 Days) | ★ 3.5M | 480.2K |
| Earning Date | 05-06-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 118.75 | N/A |
| EPS | ★ 0.18 | N/A |
| Revenue | ★ $1,076,794,000.00 | N/A |
| Revenue This Year | $17.77 | N/A |
| Revenue Next Year | $13.31 | N/A |
| P/E Ratio | $196.19 | ★ $12.91 |
| Revenue Growth | ★ 27.19 | N/A |
| 52 Week Low | $29.23 | $66.57 |
| 52 Week High | $93.88 | $203.91 |
| Indicator | Z | ICLR |
|---|---|---|
| Relative Strength Index (RSI) | 52.51 | 43.82 |
| Support Level | $34.70 | $150.86 |
| Resistance Level | $37.21 | $183.11 |
| Average True Range (ATR) | 1.45 | 6.33 |
| MACD | -0.16 | -1.29 |
| Stochastic Oscillator | 49.22 | 14.35 |
Zillow Group Inc is a real estate technology company offering a digital platform that connects real estate customers with sellers, agents, loan officers, and other real estate-related professionals. With its tools and resources, Zillow helps real estate professionals grow their businesses, and for renters and housing providers, it offers a marketplace along with a set of end-to-end products and services to streamline applications, leases, payments, and more. The group operates various brands such as Zillow, Zillow Home Loans, Zillow Rentals, Zillow New Construction, Trulia, StreetEasy, Out East, HotPads, Follow Up Boss, ShowingTime, dotloop, and Zillow Closing. Its ecosystem spans the entire home journey from shopping to renting, buying, selling, and financing real estate.
Icon is a global contract research organization that provides outsourced clinical development services to pharmaceutical and biotechnology firms. Icon supports clients across late-stage clinical trials through the regulatory approval process and postmarket studies. Icon's services include clinical trial management, patient recruitment, data analytics, laboratory services, and regulatory consulting. With more than 40,000 employees operating in over 50 countries, the company partners with life sciences firms to run clinical trials and bring new drugs to market.